Harmani Kalim, M. G. F., M. S. Rohman, D. Sargowo, S. Winarsih, D. Nugrahenny, H. Sujuti, S. N. Widhaningrum, and J. . W. Souhaly. “Empagliflozin Attenuates Cardiac Fibrosis via Suppression of TLR2/NF-κB Signaling in a Rat Model of Metabolic Syndrome”. Trends in Sciences, vol. 23, no. 9, Apr. 2026, p. 13423, doi:10.48048/tis.2026.13423.